Currently, there are 197.13M common shares owned by the public and among those 172.48M shares have been available to trade.
The company’s stock has a 5-day price change of -14.81% and 69.60% over the past three months. IREN shares are trading 83.36% year to date (YTD), with the 12-month market performance up to 126.42% higher. It has a 12-month low price of $3.56 and touched a high of $15.92 over the same period. IREN has an average intraday trading volume of 17.68 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.94%, 23.46%, and 52.52% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of IREN Ltd (NASDAQ: IREN) shares accounts for 29.07% of the company’s 197.13M shares outstanding.
It has a market capitalization of $2.50B and a beta (3y monthly) value of 3.55. The earnings-per-share (ttm) stands at -$0.41. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.31% over the week and 11.34% over the month.
Earnings per share for the fiscal year are expected to increase by 199.63%, and 391.96% over the next financial year.
Looking at the support for the IREN, a number of firms have released research notes about the stock. JP Morgan stated their Neutral rating for the stock in a research note on December 10, 2024, with the firm’s price target at $9.50-$15. ROTH MKM coverage for the IREN Ltd (IREN) stock in a research note released on October 02, 2024 offered a Buy rating with a price target of $14. Needham was of a view on September 04, 2024 that the stock is Hold, while Bernstein gave the stock Outperform rating on July 10, 2024, issuing a price target of $26. Cantor Fitzgerald on their part issued Overweight rating on June 11, 2024.
